349 related articles for article (PubMed ID: 15226309)
21. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
22. The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis.
Xi JC; Zang HY; Guo LX; Xue HB; Liu XD; Bai YB; Ma YZ
J Recept Signal Transduct Res; 2015; 35(6):640-5. PubMed ID: 26390889
[TBL] [Abstract][Full Text] [Related]
23. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
24. Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation.
Vojtek AB; Taylor J; DeRuiter SL; Yu JY; Figueroa C; Kwok RP; Turner DL
Mol Cell Biol; 2003 Jul; 23(13):4417-27. PubMed ID: 12808085
[TBL] [Abstract][Full Text] [Related]
25. Akt activation is required for TGF-β1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts.
Suzuki E; Ochiai-Shino H; Aoki H; Onodera S; Saito A; Saito A; Azuma T
PLoS One; 2014; 9(12):e112566. PubMed ID: 25470129
[TBL] [Abstract][Full Text] [Related]
26. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts.
Kang HY; Cho CL; Huang KL; Wang JC; Hu YC; Lin HK; Chang C; Huang KE
J Bone Miner Res; 2004 Jul; 19(7):1181-90. PubMed ID: 15177002
[TBL] [Abstract][Full Text] [Related]
27. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element.
Sierra OL; Cheng SL; Loewy AP; Charlton-Kachigian N; Towler DA
J Biol Chem; 2004 Jul; 279(31):32913-23. PubMed ID: 15131132
[TBL] [Abstract][Full Text] [Related]
28. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2.
Jackson RA; Murali S; van Wijnen AJ; Stein GS; Nurcombe V; Cool SM
J Cell Physiol; 2007 Jan; 210(1):38-50. PubMed ID: 17051597
[TBL] [Abstract][Full Text] [Related]
30. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways.
Ikegami D; Akiyama H; Suzuki A; Nakamura T; Nakano T; Yoshikawa H; Tsumaki N
Development; 2011 Apr; 138(8):1507-19. PubMed ID: 21367821
[TBL] [Abstract][Full Text] [Related]
31. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
Sarker KP; Lee KY
Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
[TBL] [Abstract][Full Text] [Related]
32. Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling.
Miraoui H; Severe N; Vaudin P; Pagès JC; Marie PJ
J Cell Biochem; 2010 Aug; 110(5):1147-54. PubMed ID: 20564211
[TBL] [Abstract][Full Text] [Related]
33. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
[TBL] [Abstract][Full Text] [Related]
34. Involvement of phosphoinositide 3-kinase signaling pathway in chondrocytic differentiation of ATDC5 cells: application of a gene-trap mutagenesis.
Ihara-Watanabe M; Uchihashi T; Miyauchi Y; Sakai N; Yamagata M; Ozono K; Michigami T
J Cell Biochem; 2004 Oct; 93(2):418-26. PubMed ID: 15368367
[TBL] [Abstract][Full Text] [Related]
35. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway.
Li TF; Dong Y; Ionescu AM; Rosier RN; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
Exp Cell Res; 2004 Sep; 299(1):128-36. PubMed ID: 15302580
[TBL] [Abstract][Full Text] [Related]
37. c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104.
Huang YF; Lin JJ; Lin CH; Su Y; Hung SC
J Bone Miner Res; 2012 May; 27(5):1093-105. PubMed ID: 22247071
[TBL] [Abstract][Full Text] [Related]
38. SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation.
Poser S; Impey S; Trinh K; Xia Z; Storm DR
EMBO J; 2000 Sep; 19(18):4955-66. PubMed ID: 10990459
[TBL] [Abstract][Full Text] [Related]
39. Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression.
Lee SU; Shin HK; Min YK; Kim SH
Int Immunopharmacol; 2008 May; 8(5):741-7. PubMed ID: 18387517
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
